Fluorescence-tagged metallothionein with CdTe quantum dots analyzed by the chip-CE technique
Source abstract
Abstract
ABSTRACT: Quantum dots (QDs) are fluorescence nanoparticles (NPs) with unique optic properties which allow their use as probes in chemical, biological, immunological, and molecular imaging. QDs linked with target ligands such as peptides or small molecules can be used as tumor biomarkers. These particles are a promising tool for selective, fast, and sensitive tagging and imaging in medicine. In this study, an attempt was made to use QDs as a marker for human metallothionein (MT) isoforms 1 and 2. Four kinds of CdTe QDs of different sizes bioconjugated with MT were analyzed using the chip-CE technique. Based on the results, it can be concluded that MT is willing to interact with QDs, and the chip-CE technique enables the observation of their complexes. It was also observed that changes ranging roughly 6-7 kDa, a value corresponding to the MT monomer, depend on the hydrodynamic diameters of QDs; also, the MT sample without cadmium interacted stronger with QDs than MT saturated with cadmium. Results show that MT is willing to interact with smaller QDs (blue CdTe) rather than larger ones QDs (red CdTe). To our knowledge, chip-CE has not previously been applied in the study of CdTe QDs interaction with MT.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanocluster Synthesis and Applications · Protein Interaction Studies and Fluorescence Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (85)
Show source-provided references
1. Alivisatos AP (1996) Semiconductor clusters, nanocrystals, and quantum dots. Science 271:933–937. doi: 10.1126/science.271.5251.93310.1126/science.271.5251.933 ↗
2. Andrews GK (2000) Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 59:95–10410.1016/S0006-2952(99)00301-9 ↗
3. Bizon A, Milnerowicz-Nabzdyk E, Zalewska M, Zimmer M, Milnerowicz H (2011) Changes in pro/antioxidant balance in smoking and non-smoking pregnant women with intrauterine growth restriction. Reprod Toxicol 32:360–367. doi: 10.1016/j.reprotox.2011.08.00710.1016/j.reprotox.2011.08.007 ↗
4. Bousse L, Mouradian S, Minalla A, Yee H, Williams K, Dubrow R (2001) Protein sizing on a microchip. Anal Chem 73:1207–1212. doi: 10.1021/ac001249210.1021/ac0012492 ↗
5. Brannon-Peppas L, Blanchette JO (2012) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 64:206–212. doi: 10.1016/j.addr.2012.09.03310.1016/j.addr.2012.09.033 ↗
6. Bremner I, Beattie JH (1990) Metallothionein and the trace minerals. Ann. Rev Nutr 10:63–83. doi: 10.1146/annurev.nu.10.070190.00043110.1146/annurev.nu.10.070190.000431 ↗
7. Cai L, Klein JB, Kang YJ (2000) Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J Biol Chem 275:38957–38960. doi: 10.1074/jbc.C00059320010.1074/jbc.C000593200 ↗
8. Carpene E, Andreani G, Isani G (2007) Metallothionein functions and structural characteristics. J Trace Elem Med Biol 21(Suppl 1):35–39. doi: 10.1016/j.jtemb.2007.09.01110.1016/j.jtemb.2007.09.011 ↗
9. Chan WC, Nie S (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281:2016–201810.1126/science.281.5385.2016 ↗
10. Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S (2002) Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 13:40–4610.1016/S0958-1669(02)00282-3 ↗
11. Cherian MG, Jayasurya A, Bay BH (2003) Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533:201–20910.1016/j.mrfmmm.2003.07.013 ↗
12. Chua CK, Pumera M (2013) Detection of silver nanoparticles on a lab-on-chip platform. Electrophoresis 34:2007–2010. doi: 10.1002/elps.20120042610.1002/elps.201200426 ↗
13. Chubatsu LS, Meneghini R (1993) Metallothionein protects DNA from oxidative damage. Biochem J 291(Pt 1):193–19810.1042/bj2910193 ↗
14. Coyle P, Philcox JC, Carey LC, Rofe AM (2002) Metallothionein: the multipurpose protein. Cellular and molecular life sciences 59:627–64710.1007/s00018-002-8454-2 ↗
15. Craig-Schapiro R, Fagan AM, Holtzman DM (2009) Biomarkers of Alzheimer’s disease. Neurobiol Dis 35:128–140. doi: 10.1016/j.nbd.2008.10.00310.1016/j.nbd.2008.10.003 ↗
16. Davis SR, Cousins RJ (2000) Metallothionein expression in animals: a physiological perspective on function. J Nutr 130:1085–108810.1093/jn/130.5.1085 ↗
17. Derfus AM, Chan WCW, Bhatia SN (2004) Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4:11–18. doi: 10.1021/Nl034733410.1021/nl0347334 ↗
18. Doz F, Roosen N, Rosenblum ML (1993) Metallothionein and anticancer agents: the role of metallothionein in cancer chemotherapy. J Neurooncol 17:123–12910.1007/BF01050214 ↗
19. Drbohlavova J, Adam V, Kizek R, Hubalek J (2009) Quantum dots—characterization, preparation and usage in biological systems. Int J Mol Sci 10:656–673. doi: 10.3390/ijms1002065610.3390/ijms10020656 ↗
20. Duan JL, Song LX, Zhan JH (2009) One-pot synthesis of highly luminescent CdTe quantum dots by microwave irradiation reduction and their Hg2+-sensitive properties. Nano Res 2:61–68. doi: 10.1007/s12274-009-9004-010.1007/s12274-009-9004-0 ↗
21. Dubois F, Mahler B, Dubertret B, Doris E, Mioskowski C (2007) A versatile strategy for quantum dot ligand exchange. J Am Chem Soc 129:482–483. doi: 10.1021/ja067742y10.1021/ja067742y ↗
22. Duncan KER, Stillman MJ (2006) Metal-dependent protein folding: metallation of metallothionein. J Inorg Biochem 100:2101–2107. doi: 10.1016/j.jinorgbio.2006.09.00510.1016/j.jinorgbio.2006.09.005 ↗
23. Frasco MF, Chaniotakis N (2010) Bioconjugated quantum dots as fluorescent probes for bioanalytical applications. Anal Bioanal Chem 396:229–240. doi: 10.1007/s00216-009-3033-010.1007/s00216-009-3033-0 ↗
24. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S (2005) In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 16:63–72. doi: 10.1016/j.copbio.2004.11.00310.1016/j.copbio.2004.11.003 ↗
25. Grieve K, Mulvaney P, Grieser F (2000) Synthesis and electronic properties of semiconductor nanoparticles/quantum dots. Curr Opin Colloid Interface Sci 5:168–172. doi: 10.1016/S1359-0294(00)00050-910.1016/S1359-0294(00)00050-9 ↗
26. Hamer DH (1986) Metallothionein. Ann Rev Biochem 55:913–951. doi: 10.1146/annurev.biochem.55.1.91310.1146/annurev.bi.55.070186.004405 ↗
27. Hong SH, Gohya M, Ono H, Murakami H, Yamashita M, Hirayama N, Murooka Y (2000) Molecular design of novel metal-binding oligomeric human metallothioneins. Appl Microbiol Biotechnol 54:84–8910.1007/s002530000360 ↗
28. Hoshino A et al (2004) Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 4:2163–2169. doi: 10.1021/Nl048715d10.1021/nl048715d ↗
29. Kagi JH, Schaffer A (1988) Biochemistry of metallothionein. Biochemistry 27:8509–851510.1021/bi00423a001 ↗
30. Karotki AV, Vasak M (2009) Reaction of human metallothionein-3 with cisplatin and transplatin. J Biol Inorg Chem 14:1129–1138. doi: 10.1007/s00775-009-0557-x10.1007/s00775-009-0557-x ↗
31. Koberle B, Tomicic MT, Usanova S, Kaina B (2010) Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta 1806:172–182. doi: 10.1016/j.bbcan.2010.07.004
32. Krizkova S, Adam V, Kizek R (2009a) Study of metallothionein oxidation by using of chip CE. Electrophoresis 30:4029–4033. doi: 10.1002/elps.20090022610.1002/elps.200900226 ↗
33. Krizkova S, Fabrik I, Adam V, Hrabeta J, Eckschlager T, Kizek R (2009b) Metallothionein-a promising tool for cancer diagnostics. Bratisl Lek Listy 110:93–97
34. Krizkova S, Masarik M, Eckschlager T, Adam V, Kizek R (2010a) Effects of redox conditions and zinc(II) ions on metallothionein aggregation revealed by chip capillary electrophoresis. J Chromatogr A 1217:7966–7971. doi: 10.1016/j.chroma.2010.07.02210.1016/j.chroma.2010.07.022 ↗
35. Krizkova S et al (2010b) Serum metallothionein in newly diagnosed patients with childhood solid tumours. Acta Biochim Pol 57:561–56610.18388/abp.2010_2444 ↗
36. Krizkova S et al (2011) Electrophoretic fingerprint metallothionein analysis as a potential prostate cancer biomarker. Electrophoresis 32:1952–1961. doi: 10.1002/elps.20100051910.1002/elps.201000519 ↗
37. Liu Y, Miyoshi H, Nakamura M (2007) Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer (Journal international du cancer) 120:2527–2537. doi: 10.1002/ijc.2270910.1002/ijc.22709 ↗
38. Manso Y et al (2012) Characterization of the role of metallothionein-3 in an animal model of Alzheimer’s disease. Cell Mol life Sci 69:3683–3700. doi: 10.1007/s00018-012-1047-910.1007/s00018-012-1047-9 ↗
39. Margoshes M, Vallee BL (1957) A cadmium protein from equine kidney cortex. J Am Chem Soc 79:4813–4814. doi: 10.1021/Ja01574a06410.1021/ja01574a064 ↗
40. Michalet X et al (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307:538–544. doi: 10.1126/science.110427410.1126/science.1104274 ↗
41. Milnerowicz H, Bizon A (2010) Determination of metallothionein in biological fluids using enzyme-linked immunoassay with commercial antibody. Acta Biochim Pol 57:99–10410.18388/abp.2010_2379 ↗
42. Minami T, Ichida S, Kubo K (2002) Study of metallothionein using capillary zone electrophoresis. J Chromatogr B 781:303–31110.1016/S1570-0232(02)00496-8 ↗
43. Mitchell GP, Mirkin CA, Letsinger RL (1999) Programmed assembly of DNA functionalized quantum dots. J Am Chem Soc 121:8122–8123. doi: 10.1021/ja991662v10.1021/ja991662v ↗
44. Miyawaki A, Sawano A, Kogure T (2003) Lighting up cells: labelling proteins with fluorophores. Nature Cell Biology 5:S1–S7. doi: 10.1038/ncb103110.1038/ncb0103-1 ↗
45. Moffatt P, Denizeau F (1997) Metallothionein in physiological and physiopathological processes. Drug Metab Rev 29:261–30710.3109/03602539709037585 ↗
46. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM (2008) Characterization of nanomaterial dispersion in solution prior to In vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239–253. doi: 10.1093/toxsci/kfm24010.1093/toxsci/kfm240 ↗
47. Namdarghanbari M, Wobig W, Krezoski S, Tabatabai NM, Petering DH (2011) Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem 16:1087–1101. doi: 10.1007/s00775-011-0823-610.1007/s00775-011-0823-6 ↗
48. Nielson KB, Atkin CL, Winge DR (1985) Distinct metal-binding configurations in metallothionein. J Biol Chem 260:5342–535010.1016/S0021-9258(18)89027-5 ↗
49. Niemeyer CM (2001) Nanoparticles, proteins, and nucleic acids: Biotechnology meets materials science. Angew Chem Int Edit 40:4128–4158. doi: 10.1002/1521-3773(20011119)40:22<4128:Aid-Anie4128>3.0.Co;2-S10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S ↗
50. Palumaa P, Vasak M (1992) Binding of inorganic phosphate to the cadmium-induced dimeric form of metallothionein from rabbit liver. Eur J Biochem/FEBS 205:1131–113510.1111/j.1432-1033.1992.tb16882.x ↗
51. Petersen JR, Okorodudu AO, Mohammad A, Payne DA (2003) Capillary electrophoresis and its application in the clinical laboratory. Clinica Chimica Acta 330:1–3010.1016/S0009-8981(03)00006-8 ↗
52. Pons T, Uyeda HT, Medintz IL, Mattoussi H (2006) Hydrodynamic dimensions, electrophoretic mobility, and stability of hydrophilic quantum dots. J Phys Chem B 110:20308–20316. doi: 10.1021/jp065041h10.1021/jp065041h ↗
53. Rana S, Yeh YC, Rotello VM (2010) Engineering the nanoparticle-protein interface: applications and possibilities. Curr Opin Chem Biol 14:828–834. doi: 10.1016/j.cbpa.2010.10.00110.1016/j.cbpa.2010.10.001 ↗
54. Rao J, Dragulescu-Andrasi A, Yao H (2007) Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 18:17–25. doi: 10.1016/j.copbio.2007.01.00310.1016/j.copbio.2007.01.003 ↗
55. Richards MP, Beattie JH (1995) Comparison of different techniques for the analysis of metallothionein isoforms by capillary electrophoresis. J Chromatogr B 669:27–3710.1016/0378-4347(95)00008-7 ↗
56. Righetti PG, Sebastiano R, Citterio A (2013) Capillary electrophoresis and isoelectric focusing in peptide and protein analysis. Proteomics 13:325–340. doi: 10.1002/pmic.20120037810.1002/pmic.201200378 ↗
57. Roco MC (2003) Nanotechnology: convergence with modern biology and medicine. Curr Opin Biotechnol 14:337–34610.1016/S0958-1669(03)00068-5 ↗
58. Rosenthal SJ, Chang JC, Kovtun O, McBride JR, Tomlinson ID (2011) Biocompatible quantum dots for biological applications. Chem Biol 18:10–24. doi: 10.1016/j.chembiol.2010.11.01310.1016/j.chembiol.2010.11.013 ↗
59. Ruttkay-Nedecky B et al (2013) The role of metallothionein in oxidative stress. Int J Mol Sci 14:6044–6066. doi: 10.3390/ijms1403604410.3390/ijms14036044 ↗
60. Ryvolova M, Hynek D, Skutkova H, Adam V, Provaznik I, Kizek R (2012) Structural changes in metallothionein isoforms revealed by capillary electrophoresis and Brdicka reaction. Electrophoresis 33:270–279. doi: 10.1002/elps.20110031210.1002/elps.201100312 ↗
61. Sabolic I, Breljak D, Skarica M, Herak-Kramberger CM (2010) Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs. Biometals 23:897–926. doi: 10.1007/s10534-010-9351-z10.1007/s10534-010-9351-z ↗
62. Salata O (2004) Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:3. doi: 10.1186/1477-3155-2-310.1186/1477-3155-2-3 ↗
63. Sanvicens N, Marco MP (2008) Multifunctional nanoparticles-properties and prospects for their use in human medicine. Trends Biotechnol 26:425–433. doi: 10.1016/j.tibtech.2008.04.00510.1016/j.tibtech.2008.04.005 ↗
64. Shen JC, Liu J, Zhuang ZX, Wang XR, Lee FS (2006) Investigation of zinc binding metallothioneins’ polymerization in tris(hydroxymethyl)-aminomethane buffer by coupling of size exclusion chromatography with electrospray ionization mass spectrometry. Talanta 69:988–995. doi: 10.1016/j.talanta.2005.12.00210.1016/j.talanta.2005.12.002 ↗
65. Sieradzka E, Witt K, Milnerowicz H (2014) The application of capillary electrophoresis techniques in toxicological analysis. Biomed Chromatogr 28:1507–1513. doi: 10.1002/bmc.323410.1002/bmc.3234 ↗
66. Silva AC, Silva MJ, da Luz FA, Silva DP, de Deus SL, Dantas NO (2014) Controlling the cytotoxicity of CdSe magic-sized quantum dots as a function of surface defect density. Nano Lett 14:5452–5457. doi: 10.1021/nl502802810.1021/nl5028028 ↗
67. Simpkins CO (2000) Metallothionein in human disease. Cell Mol Biol 46:465–488
68. Skalickova S et al (2013) Study of interaction between metallothionein and CdTe quantum dots. Chromatographia 76:345–353. doi: 10.1007/s10337-013-2418-610.1007/s10337-013-2418-6 ↗
69. Smejkal P, Foret F (2012) Microfluidics in bioanalytical instrumentation. Chem Listy 106:104–112
70. Smith AM, Gao XH, Nie SM (2004) Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochem Photobiol 80:377–385. doi: 10.1562/0031-8655(2004)080<0377:Qdnfiv>2.0.Co;210.1562/2004-06-21-IR-209.1 ↗
71. Sogawa N et al (2013) Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression. Life Sci 92:727–732. doi: 10.1016/j.lfs.2013.01.03110.1016/j.lfs.2013.01.031 ↗
72. Sturzenbaum SR et al (2013) Biosynthesis of luminescent quantum dots in an earthworm. Nat Nanotechnol 8:57–60. doi: 10.1038/nnano.2012.23210.1038/nnano.2012.232 ↗
73. Swinney K, Bornhop DJ (2000) Detection in capillary electrophoresis Electrophoresis 21:1239–1250. doi: 10.1002/(SICI)1522-2683(20000401)21:7<1239:AID-ELPS1239>3.0.CO;2-6
74. Terai T, Nagano T (2013) Small-molecule fluorophores and fluorescent probes for bioimaging. Pflugers Arch 465:347–359. doi: 10.1007/s00424-013-1234-z10.1007/s00424-013-1234-z ↗
75. Thormann W, Lurie IS, McCord B, Marti U, Cenni B, Malik N (2001) Advances of capillary electrophoresis in clinical and forensic analysis (1999-2000). Electrophoresis 22:4216–4243. doi: 10.1002/1522-2683(200111)22:19<4216:AID-ELPS4216>3.0.CO;2-W10.1002/1522-2683(200111)22:19<4216::AID-ELPS4216>3.0.CO;2-W ↗
76. Tmejova K et al (2014) Study of metallothionein-quantum dots interactions. Colloids Surf B 117:534–537. doi: 10.1016/j.colsurfb.2014.03.01310.1016/j.colsurfb.2014.03.013 ↗
77. Trabelsi H, Azzouz I, Sakly M, Abdelmelek H (2013) Subacute toxicity of cadmium on hepatocytes and nephrocytes in the rat could be considered as a green biosynthesis of nanoparticles. Int J Nanomed 8:1121–1128. doi: 10.2147/IJN.S3942610.2147/IJN.S39426 ↗
78. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M (1991) The growth inhibitory factor that is deficient in the Alzheimer’s disease brain is a 68 amino acid metallothionein-like protein. Neuron 7:337–34710.1016/0896-6273(91)90272-2 ↗
79. Vasak M, Meloni G (2011) Chemistry and biology of mammalian metallothioneins. J Biol Inorg Chem 16:1067–1078. doi: 10.1007/s00775-011-0799-210.1007/s00775-011-0799-2 ↗
80. Waalkes MP, Harvey MJ, Klaassen CD (1984) Relative in vitro affinity of hepatic metallothionein for metals. Toxicol Lett 20:33–39. doi: 10.1016/0378-4274(84)90179-610.1016/0378-4274(84)90179-6 ↗
81. Wang LY, Li YD (2007) Controlled synthesis and luminescence of lanthanide doped NaYF4 nanocrystals. Chem Mater 19:727–734. doi: 10.1021/Cm061887m10.1021/cm061887m ↗
82. Wang H et al (2006) Solution structure and dynamics of human metallothionein-3 (MT-3). FEBS Lett 580:795–800. doi: 10.1016/j.febslet.2005.12.09910.1016/j.febslet.2005.12.099 ↗
83. Zalewska M, Bizon A, Milnerowicz H (2011) Comparison of capillary electrophoretic techniques for analysis and characterization of metallothioneins. J Sep Sci 34:3061–3069. doi: 10.1002/jssc.20110037910.1002/jssc.201100379 ↗
84. Zalewska M, Trefon J, Milnerowicz H (2014) The role of metallothionein interactions with other proteins. Proteomics 14:1343–1356. doi: 10.1002/pmic.20130049610.1002/pmic.201300496 ↗
85. Zhu ZF, Lu JJ, Liu SR (2012) Protein separation by capillary gel electrophoresis: a review. Anal Chim Acta 709:21–31. doi: 10.1016/j.aca.2011.10.02210.1016/j.aca.2011.10.022 ↗